Clinical trials: Type 1 Diabetes, Pregnancy
Type 1 Diabetics Who Are Pregnant or Planning Pregnancy
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.
- Trial name
- CONCEPTT (NCT01788527)
- Testing
- CGM
- Where
- 31 sites in United States, Canada and 4 more
- Volunteers
- 325 people
- Sponsor
- Mount Sinai Hospital, Canada
Diabetes Mellitus, Intrahepatic Cholestasis of Pregnancy
Magnetic Resonance Imaging and Thermal Imaging of Adiposity in Neonates of Women With Metabolic Diseases
There is limited knowledge about the extent of the impact of maternal metabolic diseases (MD) and/or alterations in maternal serum lipid content upon neonatal lipid distribution and phenotypes.
- Conditions
- Diabetes Mellitus, Intrahepatic Cholestasis of Pregnancy, Metabolic Disease
- Trial name
- MRI-TIME (NCT04890886)
- Testing
- Thermal imaging, Echocardiogram, ECG
- Volunteers
- 80 people
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
Type 1 Diabetes, Pregnancy
Pancreatic Islet Mass in Pregnancy in Type 1 Diabetes
Type 1 diabetic women have a decrease in insulin requirements during early pregnancy. Preliminary evidence suggests this decrease may be secondary to the regeneration of pancreatic B-cells during pregnancy During the second and…
- Trial name
- NCT00548522
- Where
- 2 sites in Canada
- Volunteers
- 12 people
- Sponsor
- University of Alberta
Type 1 Diabetes Mellitus
The MICRON Study - A Steno 1 Substudy
The goal of this observational study is to compare cardiac and renal oxygen consumption among subjects with type 1 diabetes treated with either multifactorial intervention or according to the current standard care.
- Trial name
- MICRON (NCT07270172)
- Where
- 5 sites in Denmark
- Volunteers
- 40 people
- Sponsor
- University of Aarhus
Pregnancy, Diabetes
Severe Hypoglycemia in Pregnant Women With Type 1 Diabetes
Background: The risk of stillbirth and preterm delivery is three times increased among pregnant women with type 1 diabetes compared with healthy pregnant women.
- Trial name
- NCT00435565
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Diabetes Mellitus
Studies of Organ Transplantation in Animals and Man
A. To study the effects of pancreas transplantation (PT) on the structural abnormalities of diabetic nephropathy (DN) in patients with type 1 (insulin-dependent) diabetes mellitus (type 1 D).
- Trial name
- NCT00156364
- Where
- United States
- Volunteers
- 655 people
- Sponsor
- Michael Mauer, MD
Type 1 Diabetes
Closed-Loop Insulin Delivery During Pregnancy (IADIABENCEINTE)
The imbalance of diabetes is associated with an increased risk of maternal and fetal complications. In women, it can cause abortion, hypertension, preeclampsia, and obstructed labor; in the fetus, it increases the risk of many…
- Trial name
- IADIABENCEIN (NCT05661149)
- Testing
- Hybrid closed loop insulin delivery systems
- Where
- France
- Volunteers
- 14 people
- Sponsor
- Centre Hospitalier Sud Francilien
Diabetes, Pregnancy
Physical Activity During Pregnancy in Women With Pre-existing Diabetes
Pregnancy can be more challenging for women with pre-existing (Type 1 or Type 2 diabetes) because it increases the risk of complications such as early births or babies being born larger than usual.
- Trial name
- PA-DIP (NCT07581106)
- Testing
- Physical Activity
- Volunteers
- 175 people
- Sponsor
- University of Exeter
Chronic Kidney Disease(CKD), Type 1 Diabetes (T1D)
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and…
- Trial name
- NCT06694558
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- The Cleveland Clinic
Diabetic Nephropathy, Type 2 Diabetes Mellitus
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
The purpose of the study is to evaluate the effectiveness and safety of olmesartan versus placebo on the progression of diabetic renal disease.
- Conditions
- Diabetic Nephropathy, Type 2 Diabetes Mellitus, Proteinuria
- Trial name
- NCT00141453
- Testing
- olmesartan medoxomil
- Where
- 2 sites in China, Japan
- Volunteers
- 577 people
- Sponsor
- Daiichi Sankyo Co., Ltd.
Diabetic Kidney Disease, Type 1 Diabetes
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
Diabetic kidney disease (DKD) is a leading cause of chronic and end-stage kidney disease, affecting 25-40% of type 1 diabetes (T1D) patients and 5-40% of type 2 diabetes (T2D) patients.
- Trial name
- NCT06532682
- Testing
- dapagliflozin, ACE inhibitor
- Where
- China
- Volunteers
- 54 people
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
Type 1 Diabetes, End Stage Renal Disease
Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation
Islet transplantation is a promising treatment of type 1 diabetes in selected cases. Results are however hampered by a relatively low number of islets surviving the transplantation into the liver, which currently is the site for…
- Trial name
- NCT01967186
- Testing
- Intraportal islet transplantation, Intramuscular islet transplantation, Intramuscular transpl with stemcells
- Volunteers
- 36 people
- Sponsor
- The Nordic Network For Clinical Islet Transplantation
Diabetic Nephropathy
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
OBJECTIVES: I. Establish a long-term working relationship between clinical investigators and the Minnesota American Indian community. II.
- Trial name
- NCT00004266
- Testing
- Lisinopril, Nifedipine, Simvastatin
- Where
- United States
- Volunteers
- 160 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus
Diabetes Mellitus and Pregnancy : Knowledge Assessment
Diabetes, a chronic and frequent disease, is a risk factor of pregnancy complications such as preeclampsia, congenital malformations and macrosomia.
- Trial name
- DMPKA (NCT04350879)
- Testing
- Data record
- Where
- France
- Volunteers
- 122 people
- Sponsor
- CHU de Reims
Microalbuminuria, Diabetic Nephropathy
Chicken-Diet vs. Enalapril to Reduce Albuminuria
Diabetic nephropathy (DN) is a chronic diabetic complication and affects up to 40% of patients. The first line treatment for DN is angiotensin blockers drugs that are used to reduce the protein concentration in urine.Previous…
- Trial name
- NCT00484068
- Testing
- enalapril, chicken diet
- Where
- Brazil
- Volunteers
- 28 people
- Sponsor
- Hospital de Clinicas de Porto Alegre
Type 1 Diabetes, Pregnancy, High Risk
Commercial or Open Source Closed Loop Impact on Pregnancy Study
The goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems.
- Conditions
- Type 1 Diabetes, Pregnancy, High Risk, Insulin Dependent Diabetes, Pregnancy Related
- Trial name
- COSCLIP (NCT06654713)
- Testing
- Commercial AID system, Open source AID system
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- University of California, San Francisco
Diabetes Mellitus, Nephropathy
A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria
A double blind, randomized, cross over study in type 1 diabetic patients. 20 patients, age 18-65 years is treated with spironolacton (Hexalacton (R)) for 60 days followed by 60 days treatment with placebo(or opposite).
- Conditions
- Diabetes Mellitus, Nephropathy, Blood Pressure
- Trial name
- NCT00843388
- Testing
- Spironolacton (hexalacton(R))
- Volunteers
- 20 people
- Sponsor
- Steno Diabetes Center Copenhagen
Type 1 Diabetes Mellitus With Diabetic Nephropathy
Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children
About 30 to 40% of patients suffering from type I diabetes are at risk of developing a diabetic nephropathy (DN) leading more or less rapidly to an end-stage renal disease.
- Trial name
- peeDIAB2 (NCT02164279)
- Testing
- Urinary sample collection
- Where
- 2 sites in France
- Volunteers
- 150 people
- Sponsor
- University Hospital, Toulouse
Diabetic Nephropathies, Coronary Artery Disease
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
Despite improvements during the past 20 years in blood glucose and blood pressure control, diabetic kidney disease remains one of the most important causes of health problems in patients with diabetes.
- Trial name
- NCT02017171
- Testing
- Allopurinol
- Where
- 30 sites in United States, Canada and 1 more
- Volunteers
- 530 people
- Sponsor
- Alessandro Doria
Coronary Disease, Myocardial Infarction
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
The CLIMATE Observational Study examines to what extent chronically ill patients experience adverse health effects because of heat and whether the patients' specific efforts, somatosensory amplification, self-efficacy, health…
- Conditions
- Coronary Disease, Myocardial Infarction, Heart Failure, Arrhythmias, Cardiac
- Trial name
- CLIMATE (NCT05961163)
- Where
- Germany
- Volunteers
- 61 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf